These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 24120891

  • 21. US policy may encourage counterfeit drugs.
    Bouchie A.
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract] [Full Text] [Related]

  • 22. Swiss patent proposal prompts criticism.
    Burgermeister J.
    Nat Biotechnol; 2004 Oct; 22(10):1323. PubMed ID: 15521096
    [No Abstract] [Full Text] [Related]

  • 23. History of a gene patent: tracing the development and application of commercial BRCA testing.
    Williams-Jones B.
    Health Law J; 2002 Oct; 10():123-46. PubMed ID: 14748275
    [No Abstract] [Full Text] [Related]

  • 24. Patenting race.
    Kahn J.
    Nat Biotechnol; 2006 Nov; 24(11):1349-51. PubMed ID: 17093476
    [Abstract] [Full Text] [Related]

  • 25. India's IP snub.
    Jayaraman KS.
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract] [Full Text] [Related]

  • 26. Biotechnology products and university-based science.
    Sobolski GK.
    JAMA; 2005 Jun 15; 293(23):2862; author reply 2863. PubMed ID: 15956629
    [No Abstract] [Full Text] [Related]

  • 27. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP, Deng MM.
    Nat Biotechnol; 2008 Nov 15; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract] [Full Text] [Related]

  • 28. Biotech reels over patent ruling.
    Check-Hayden E.
    Nature; 2014 Jul 10; 511(7508):138. PubMed ID: 25008505
    [No Abstract] [Full Text] [Related]

  • 29. Indirect infringement.
    Becker DM.
    Nat Rev Drug Discov; 2006 Mar 10; 5(3):181. PubMed ID: 16557655
    [No Abstract] [Full Text] [Related]

  • 30. Putting your best mode forward.
    Tsao YR, Tabtiang RK.
    Nat Biotechnol; 2000 Oct 10; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract] [Full Text] [Related]

  • 31. Protecting rights to early-stage technology.
    Shuster MJ, Su H, Blaug S.
    Nat Biotechnol; 2003 Jun 10; 21(6):701-3. PubMed ID: 12776151
    [No Abstract] [Full Text] [Related]

  • 32. Conflicts brewing as phage display gets complex.
    Glaser V.
    Nat Biotechnol; 1997 Jun 10; 15(6):506. PubMed ID: 9181564
    [No Abstract] [Full Text] [Related]

  • 33. Bills target biosimilar drugs.
    Wadman M.
    Nature; 2009 Mar 26; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract] [Full Text] [Related]

  • 34. Patent drop reveals pressures on industry.
    Lawrence S.
    Nat Biotechnol; 2004 Aug 26; 22(8):930-1. PubMed ID: 15286630
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Biotechnology products and university-based science.
    Korn D, Heinig SJ.
    JAMA; 2005 Jun 15; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract] [Full Text] [Related]

  • 38. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.
    Holman CM.
    Trends Biotechnol; 2007 Dec 15; 25(12):539-43. PubMed ID: 17983675
    [Abstract] [Full Text] [Related]

  • 39. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L.
    Lakartidningen; 2007 Dec 15; 102(39):2737. PubMed ID: 16245544
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.